Investigating the Roles of Small STBEV’s Micrornas in the Pathogenesis of Early-Onset Preeclampsia through Bioinformatics.

Awoyemi, Toluwalase; Zhang, Wei; Tanetta, Dionne; Collett, Gavin; Logenthiran, Prassana; Kandžija, Neva; Rahbar, Maryam; Jiang, Shuhan; Redman, C.W.G.; Vatish, Manu

doi:10.1016/j.placenta.2021.07.080

Search citation statements

Order By: Relevance

Paper Sections

Select...

Future Direction In Screening For Preeclampsia1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently, the differential expression of cargoes carried within STB-EVs in PE and normal pregnancy have been explored and it could be the future of early screening, diagnosis, and monitoring disease prognosis 39,40 . EVs in general have been already used in the diagnosis of breast, pancreatic, and colorectal cancers [41][42][43][44] .…”

Section: Future Direction In Screening For Preeclampsiamentioning

confidence: 99%

Early screening for preeclampsia: A myth or a reality?

Logeeswaran,

Jayawardane,

Logenthiran

2023

Sri Lanka J Obstet & Gynae

View full text Add to dashboard Cite

Preeclampsia (PE) is a hypertensive disorder in pregnancy affecting 2-8% of pregnancies worldwide and remains one of the leading causes of maternal and neonatal morbidity and mortality. PE is characterized by hypertension and end-organ damage secondary to oxidative stress, endothelial dysfunction, and vasoconstriction. The pathophysiology of the disease being elusive, early screening, diagnosis, and effective management of PE is challenging. Traditionally several predictive models including clinical and biochemical parameters have been used to stratify the risk of developing PE in pregnancy. Poor sensitivity and specificity of these models have been a limitation and has inspired the clinical world to explore more tools to screen and diagnose PE prior to the onset of clinical syndrome. This review attempts to highlight the recent developments in the newly developed screening tools and explores the future direction of preeclampsia screening research.

show abstract